AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
18.95
+0.30 (1.61%)
At close: Mar 28, 2025, 4:00 PM
19.04
+0.09 (0.48%)
After-hours: Mar 28, 2025, 7:55 PM EDT
AnaptysBio Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for AnaptysBio stock have an average target of 36.38, with a low estimate of 20 and a high estimate of 51. The average target predicts an increase of 91.98% from the current stock price of 18.95.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AnaptysBio stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 2 | 2 | 2 | 1 |
| Buy | 5 | 5 | 5 | 5 | 6 | 5 |
| Hold | 2 | 2 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 12 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $36 → $42 | Buy | Maintains | $36 → $42 | +121.64% | Mar 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $22 | Hold | Reiterates | $22 | +16.09% | Mar 4, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $40 → $51 | Buy | Maintains | $40 → $51 | +169.13% | Feb 13, 2025 |
| Wedbush | Wedbush | Buy Maintains $40 | Buy | Maintains | $40 | +111.08% | Feb 7, 2025 |
| Wolfe Research | Wolfe Research | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 4, 2025 |
Financial Forecast
Revenue This Year
37.98M
from 91.28M
Decreased by -58.40%
Revenue Next Year
60.54M
from 37.98M
Increased by 59.43%
EPS This Year
-5.50
from -5.12
EPS Next Year
-5.32
from -5.50
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 102.5M | 207.9M | 134.4M | ||
| Avg | 38.0M | 60.5M | 62.1M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.3% | 447.5% | 122.0% | ||
| Avg | -58.4% | 59.4% | 2.6% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -3.81 | -1.47 | -2.75 | ||
| Avg | -5.50 | -5.32 | -5.87 | ||
| Low | -6.53 | -6.79 | -10.56 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.